Furthermore, the pathophysiological role of CD80 in FSGS is not excluded, since the use of abatacept (CTLA-4-Ig) has been shown to reduce substantially proteinuria in FSGS [77]. The gene discussed is CTLA4; the disease is focal segmental glomerulosclerosis.